Baystate Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2
Closed 700
2020
Q3
$0 Buy
+2
New +$173 ﹤0.01% 664
2019
Q4
Sell
-60
Closed -$5K 635
2019
Q3
$5K Hold
60
﹤0.01% 415
2019
Q2
$7K Hold
60
﹤0.01% 391
2019
Q1
$6K Hold
60
﹤0.01% 425
2018
Q4
$5K Hold
60
﹤0.01% 438
2018
Q3
$4K Hold
60
﹤0.01% 451
2018
Q2
$4K Buy
60
+50
+500% +$2.69K ﹤0.01% 470
2018
Q1
$1K Buy
+10
New +$488 ﹤0.01% 561

Other funds holding EXAS

Baystate Wealth Management's EXAS Position: Q4 2020 in Review

Baystate Wealth Management sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 2 shares.

Baystate Wealth Management first reported a position in EXAS in Q1 2018 and held it in 8 quarters. The position peaked at $7K in Q2 2019. 622 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • Baystate Wealth Management reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 2 Exact Sciences shares in Q4 2020.
  • Baystate Wealth Management first reported a position in Exact Sciences in Q1 2018 and held it in 8 quarters.
  • Baystate Wealth Management's Exact Sciences position peaked at $7K in Q2 2019.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Baystate Wealth Management's 13F filing for Q4 2020, filed 15 Jan 2021.